Ortin Global Limited share price
NSE: ORTINGLOBE · ISIN INE749B01020
Key numbers
- Market cap
- ₹ 12.4 Cr
- Current price
- ₹ 15.23
- 52-week high / low
- ₹ 21 / 11
- Stock P/E
- -
- Book value
- ₹ 1.3
- Dividend yield
- 0.00%
- ROCE
- -32.2%
- ROE
- -46.0%
- Debt to equity
- 0.81
- Sales growth (3 yrs)
- -74.5%
- Profit growth (3 yrs)
- -
- 1-year return
- 25.3%
About Ortin Global Limited
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulcerants, anti-spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti-retroviral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti-ulcerants, and anti-malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development,…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 |
| Operating profit | -0 | -1 | -0 | -0 | -0 |
| Net profit | -0 | -1 | -0 | -0 | -0 |
| EPS (₹) | -0.22 | -0.62 | -0.07 | -0.01 | -0.42 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.